Product NDC: | 0065-0665 |
Proprietary Name: | Iopidine |
Non Proprietary Name: | apraclonidine |
Active Ingredient(s): | 5 mg/mL & nbsp; apraclonidine |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0065-0665 |
Labeler Name: | Alcon Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020258 |
Marketing Category: | NDA |
Start Marketing Date: | 19931001 |
Package NDC: | 0065-0665-10 |
Package Description: | 10 mL in 1 BOTTLE (0065-0665-10) |
NDC Code | 0065-0665-10 |
Proprietary Name | Iopidine |
Package Description | 10 mL in 1 BOTTLE (0065-0665-10) |
Product NDC | 0065-0665 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | apraclonidine |
Dosage Form Name | SOLUTION |
Route Name | OPHTHALMIC |
Start Marketing Date | 19931001 |
Marketing Category Name | NDA |
Labeler Name | Alcon Laboratories, Inc. |
Substance Name | APRACLONIDINE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |